MCA logo



FDA Approves Ublituximab for Relapsing Forms of Multiple Sclerosis

Multiple Sclerosis

In Dec 2022, the FDA approved BRIUMVI™, a chimeric monoclonal antibody (mAb) labelled for the treatment of RMS . . .

Sign Up or Log In as a healthcare professional to read the full article.

Share via

Also worth reading

People also read:

joss stick seven month hungry ghost
Hungry Ghost Festival Shock: Burning Joss Sticks Linked to Cancer

With the seventh month of the lunar calendar (more popularly known as the hungry ghost festival) upon us, many acts of worship will be taking place. But did you know, that the act of burning joss sticks could cause cancer? The burning of joss sticks, an integral part of many religious practices in Asia, could be as deadly as traffic fumes and cigarettes.

Read More »